| Study |
Reference |
|
Alwan, 2007
|
Alwan Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med 2007; 356:2684-92
|
|
Ames, 2021
|
Ames Maternal Psychiatric Conditions, Treatment With Selective Serotonin Reuptake Inhibitors, and Neurodevelopmental Disorders. Biol Psychiatry 2021; 90:253-262
|
|
Andersen, 2014
|
Andersen Exposure to selective serotonin reuptake inhibitors in early pregnancy and the risk of miscarriage. Obstet Gynecol 2014; 124:655-661 Kjaersgaard Prenatal antidepressant exposure and risk of spontaneous abortion - a population-based study. PLoS One 2013; 8:e72095
|
|
Anderson, 2020
|
Alwan Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med 2007; 356:2684-92 Anderson Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects. JAMA Psychiatry 2020; 77(12):1246-1255. Lind Maternal medication and herbal use and risk for hypospadias: data from the National Birth Defects Prevention Study, 1997-2007. Pharmacoepidemiol Drug Saf 2013; 22:783-93 Nembhard Maternal and infant genetic variants, maternal periconceptional use of selective serotonin reuptake inhibitors, and risk of congenital heart defects in offspring: population based study. BMJ 2017; 356:j832 Werler Gastroschisis and Cumulative Stressor Exposures. Epidemiology 2018; 29:721-728
|
|
Bakker, 2010
|
Bakker MK First-trimester use of paroxetine and congenital heart defects: a population-based case-control study. Birth Defects Res A Clin Mol Teratol 2010;88:94-100
|
|
Ban (Controls unexposed, disease free), 2014
|
Ban L Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study. BJOG 2014;121:1471-81
|
|
Ban (Controls unexposed, sick), 2014
|
Ban L Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study. BJOG 2014;121:1471-81
|
|
Bérard, 2017
|
Bérard Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort. BMJ Open 2017; 7:e013372 Ramos Duration of antidepressant use during pregnancy and risk of major congenital malformations. Br J Psychiatry 2008; 192:344-50
|
|
Bérard, 2016
|
Bérard Selective serotonin reuptake inhibitors and autism: additional data on the Quebec Pregnancy/Birth Cohort. Am J Obstet Gynecol 2016; 215:803-805
|
|
Brown, 2017
|
Brown HK Association Between Serotonergic Antidepressant Use During Pregnancy and Autism Spectrum Disorder in Children. JAMA 2017;317:1544-1552
|
|
Calderon-Margalit, 2009
|
Calderon-Margalit Risk of preterm delivery and other adverse perinatal outcomes in relation to maternal use of psychotropic medications during pregnancy. Am. J. Obstet. Gynecol. 2009; 201:579.e1-8
|
|
Chambers, 2006
|
Chambers CD Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 2006;354:579-87
|
|
Chan (Controls exposed to TCA), 2024
|
Chan Prenatal antidepressant use and risk of congenital malformations: A population-based cohort study. Psychiatry Res 2024; 339:116038
|
|
Chan (Controls unexposed, pop general), 2024
|
Chan Prenatal antidepressant use and risk of congenital malformations: A population-based cohort study. Psychiatry Res 2024; 339:116038
|
|
Colvin, 2011
|
Colvin L Dispensing patterns and pregnancy outcomes for women dispensed selective serotonin reuptake inhibitors in pregnancy. Birth Defects Res A Clin Mol Teratol 2011;91:142-52
|
|
Colvin, 2012
|
Colvin Early morbidity and mortality following in utero exposure to selective serotonin reuptake inhibitors: a population-based study in Western Australia. CNS Drugs 2012; 26:e1-14
|
|
Costei (Controls unexposed, NOS), 2002
|
Costei AM Perinatal outcome following third trimester exposure to paroxetine. Arch Pediatr Adolesc Med 2002;156:1129-32
|
|
Costei (Controls unexposed, sick), 2002
|
Costei AM Perinatal outcome following third trimester exposure to paroxetine. Arch Pediatr Adolesc Med 2002;156:1129-32
|
|
Dandjinou, 2019
|
Dandjinou Antidepressant use during pregnancy and the risk of gestational diabetes mellitus: a nested case-control study. BMJ Open 2019; 9:e025908
|
|
Davis, 2007
|
Davis Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy. Pharmacoepidemiol Drug Saf 2007; 16:1086-94
|
|
De Jonge, 2013
|
de Jonge Identifying associations between maternal medication use and birth defects using a case-population approach: an exploratory study on signal detection. Drug Saf 2013; 36:1069-78
|
|
De Vera, 2012
|
De Vera Antidepressant use during pregnancy and the risk of pregnancy-induced hypertension. Br J Clin Pharmacol 2012; 74:362-9
|
|
Diav-Citrin, 2008
|
Diav-Citrin O Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study. Br J Clin Pharmacol 2008;66:695-705 Winterfeld Pregnancy outcome following maternal exposure to mirtazapine: a multicenter, prospective study. J Clin Psychopharmacol 2015; 35:250-9
|
|
Dubnov-Raz, 2008
|
Dubnov-Raz Antenatal use of selective serotonin-reuptake inhibitors and QT interval prolongation in newborns. Pediatrics 2008; 122:e710-5
|
|
Einarson, 2008
|
Einarson A Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy. Am J Psychiatry 2008;165:749-52
|
|
Einarson, 2009
|
Einarson A Incidence of major malformations in infants following antidepressant exposure in pregnancy: results of a large prospective cohort study. Can J Psychiatry 2009;54:242-6
|
|
Furu, 2015
|
Furu K Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design. BMJ 2015;350:h1798 Kornum JB Use of selective serotonin-reuptake inhibitors during early pregnancy and risk of congenital malformations: updated analysis. Clin Epidemiol 2010;2:29-36
|
|
Heuvelman, 2023
|
Heuvelman Antidepressants in pregnancy: applying causal epidemiological methods to understand service-use outcomes in women and long-term neurodevelopmental outcomes in exposed children. Health Technol Assess 2023; 27:1-83
|
|
Huybrechts (Controls unexposed, NOS), 2014
|
Huybrechts KF Antidepressant use in pregnancy and the risk of cardiac defects. N Engl J Med 2014;370:2397-407
|
|
Huybrechts (Controls unexposed, sick), 2014
|
Huybrechts KF Antidepressant use in pregnancy and the risk of cardiac defects. N Engl J Med 2014;370:2397-407
|
|
Jimenez-Solem (Controls unexposed, NOS), 2012
|
Jimenez-Solem E Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort study. BMJ Open 2012;2:
|
|
Jimenez-Solem (Controls unexposed, sick), 2012
|
Jimenez-Solem E Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort study. BMJ Open 2012;2:
|
|
Jordan, 2016
|
Jordan S Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in Pregnancy and Congenital Anomalies: Analysis of Linked Databases in Wales, Norway and Funen, Denmark. PLoS One 2016;11:e0165122 Knudsen TM Increased risk of severe congenital heart defects in offspring exposed to selective serotonin-reuptake inhibitors in early pregnancy--an epidemiological study using validated EUROCAT data. BMC Pregnancy Childbirth 2014;14:333
|
|
Kerr, 2018
|
Kerr Risk factors for congenital microcephaly in the pre-Zika era. Birth Defects Res 2019; 111:96-118
|
|
Kieler, 2012
|
Kieler H Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries. BMJ 2012;344:d8012
|
|
Kitchin, 2022
|
Kitchin The role of prenatal exposure to antidepressants, anxiolytic, and hypnotics and its underlying illness on the risk of miscarriage using BIFAP database. Pharmacoepidemiol Drug Saf 2022; :
|
|
Kivistö, 2016
|
Kivisto Maternal Use of Selective Serotonin Reuptake Inhibitors and Lengthening of the Umbilical Cord: Indirect Evidence of Increased Foetal Activity-A Retrospective Cohort Study. PLoS One 2016; 11:e0154628
|
|
Lee (Controls exposed to TCAs), 2025
|
Lee Antidepressant use during pregnancy and risk of obstetrics and neonatal outcomes: A propensity score-weighted population-based cohort study in 2003-2018. Eur Neuropsychopharmacol 2025; 96:36-45
|
|
Lee (Controls unexposed, general pop), 2025
|
Lee Antidepressant use during pregnancy and risk of obstetrics and neonatal outcomes: A propensity score-weighted population-based cohort study in 2003-2018. Eur Neuropsychopharmacol 2025; 96:36-45
|
|
Levinson-Castiel, 2006
|
Levinson-Castiel Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Arch Pediatr Adolesc Med 2006; 160:173-6
|
|
Liu, 2017
|
Liu Antidepressant use during pregnancy and psychiatric disorders in offspring: Danish nationwide register based cohort study. BMJ 2017; 358:j3668
|
|
Louik, 2007
|
Louik First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N. Engl. J. Med. 2007; 356:2675-83
|
|
Malm, 2011
|
Malm H Selective serotonin reuptake inhibitors and risk for major congenital anomalies. Obstet Gynecol 2011;118:111-20
|
|
Marks (Controls exposed to Bupropion), 2021
|
Marks Comparing newborn outcomes after prenatal exposure to individual antidepressants: A retrospective cohort study. Pharmacotherapy 2021; 41:907-914
|
|
Marks (Controls unexposed, sick), 2021
|
Marks Comparing newborn outcomes after prenatal exposure to individual antidepressants: A retrospective cohort study. Pharmacotherapy 2021; 41:907-914
|
|
Martin, 2024
|
Martin Antidepressant use during pregnancy and birth outcomes: analysis of electronic health data from the UK, Norway, and Sweden. medRxiv 2024; :
|
|
Maschi, 2008
|
Maschi S Neonatal outcome following pregnancy exposure to antidepressants: a prospective controlled cohort study. BJOG 2008;115:283-9
|
|
Merlob, 2009
|
Merlob P Are selective serotonin reuptake inhibitors cardiac teratogens? Echocardiographic screening of newborns with persistent heart murmur. Birth Defects Res A Clin Mol Teratol 2009;85:837-41
|
|
Nakhai-Pour, 2010
|
Nakhai-Pour Use of antidepressants during pregnancy and the risk of spontaneous abortion. CMAJ 2010; 182:1031-7
|
|
Nijenhuis (Controls exposed to TCA), 2012
|
Nijenhuis Disturbed development of the enteric nervous system after in utero exposure of selective serotonin re-uptake inhibitors and tricyclic antidepressants. Part 2: Testing the hypotheses. Br J Clin Pharmacol 2012; 73:126-34
|
|
Nijenhuis (Controls unexposed, NOS), 2012
|
Nijenhuis Disturbed development of the enteric nervous system after in utero exposure of selective serotonin re-uptake inhibitors and tricyclic antidepressants. Part 2: Testing the hypotheses. Br J Clin Pharmacol 2012; 73:126-34
|
|
Nordeng (Controls unexposed, NOS), 2012
|
Nordeng H Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study. J Clin Psychopharmacol 2012;32:186-94
|
|
Nordeng (Controls unexposed, sick), 2012
|
Nordeng H Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study. J Clin Psychopharmacol 2012;32:186-94
|
|
Oberlander, 2008
|
Oberlander TF Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data. Birth Defects Res B Dev Reprod Toxicol 2008;83:68-76
|
|
Oberlander, 2004
|
Oberlander Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure. J Clin Psychiatry 2004; 65:230-7
|
|
Ozturk, 2016
|
Ozturk, Z. Safety of psychotropic medications in pregnancy: An observational cohort study Klinik Psikofarmakoloji Bulteni 2016; 26:229-.
|
|
Palmsten (Controls exposed to TCA), 2013
|
Palmsten Antidepressant use and risk for preeclampsia. Epidemiology 2013; 24:682-91
|
|
Palmsten (Controls unexposed, sick), 2013
|
Palmsten Antidepressant use and risk for preeclampsia. Epidemiology 2013; 24:682-91
|
|
Palmsten b, 2013
|
Palmsten Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States. BMJ 2013; 347:f4877
|
|
Rai (Controls exposed to TCA), 2017
|
Rai Antidepressants during pregnancy and autism in offspring: population based cohort study. BMJ 2017; 358:j2811 Rai Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study. BMJ 2013; 346:f2059
|
|
Rai (Controls unexposed, disease free), 2017
|
Rai Antidepressants during pregnancy and autism in offspring: population based cohort study. BMJ 2017; 358:j2811
|
|
Rai (Controls unexposed, sick), 2017
|
Rai Antidepressants during pregnancy and autism in offspring: population based cohort study. BMJ 2017; 358:j2811
|
|
Reis (Controls exposed to TCA), 2010
|
Källen Antidepressant drugs during pregnancy and infant congenital heart defect. Reprod Toxicol 2006; 21:221-2 Reis Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data. Psychol Med 2010; 40:1723-33
|
|
Reis (Controls unexposed, NOS), 2010
|
Kallen Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations. Birth Defects Res A Clin Mol Teratol 2007; 79:301-8 Källen Antidepressant drugs during pregnancy and infant congenital heart defect. Reprod Toxicol 2006; 21:221-2 Reis Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data. Psychol Med 2010; 40:1723-33
|
|
Stephansson, 2013
|
Stephansson Selective serotonin reuptake inhibitors during pregnancy and risk of stillbirth and infant mortality.,Selective serotonin reuptake inhibitors during pregnancy and risk of stillbirth and infant mortality. JAMA 2013; 309:48-54
|
|
Van der Veere, 2020
|
van der Veere Intra-uterine exposure to selective serotonin reuptake inhibitors (SSRIs), maternal psychopathology, and neurodevelopment at age 2.5years - Results from the prospective cohort SMOK study. Early Hum Dev 2020; 147:105075
|
|
Vial, 2006
|
Vial Paroxetine and congenital malformations: A prospective comparative study Drug Saf. 2006, 29: 911-1010.
|
|
Viktorin (Controls unexposed, NOS), 2017
|
Viktorin Autism risk following antidepressant medication during pregnancy. Psychol Med 2017; 47:2787-2796
|
|
Viktorin (Controls unexposed, sick), 2017
|
Viktorin Autism risk following antidepressant medication during pregnancy. Psychol Med 2017; 47:2787-2796
|
|
Wemakor, 2015
|
Wemakor A Selective serotonin reuptake inhibitor antidepressant use in first trimester pregnancy and risk of specific congenital anomalies: a European register-based study. Eur J Epidemiol 2015;30:1187-98
|
|
Yaris, 2005
|
Yaris Psychotropic drugs in pregnancy: a case-control study. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005; 29:333-8
|
|
Yazdy, 2014
|
Yazdy Use of selective serotonin-reuptake inhibitors during pregnancy and the risk of clubfoot. Epidemiology 2014; 25:859-65
|
